Law360, New York (January 29, 2008, 12:00 AM ET) -- The federal judge presiding over the Fosamax case has dismissed a host of claims connected to a push for a dental monitoring class in the multidistrict litigation that centers around whether Merck & Co.'s osteoporosis medication leads to painful deterioration of the jaw.
U.S. District Judge John Keenan bounced with prejudice Monday the remaining class claims connected to a quartet of suits that had been seeking certification for the medical monitoring of patients who had yet to develop osteonecrosis.
Earlier this month, Judge Keenan batted down...
Fosamax Judge Tosses Leftover Class Action Claims
To view the full article, take a free trial now.
